genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2019
Gastroenterology
Drug Discovery
Takeda Licenses COUR’s Celiac Disease Candidate after Successful Phase IIa Trial
Industry News
Shire Board Sets Stage for $64B Takeda Acquisition, If Companies Resolve Details
Industry News
Ferring, ICF Partner to Develop IBD Treatment
Industry News
Allergan to Acquire Tobira for Up to $1.695B
Industry News
Allergan Buys RetroSense Therapeutics for $60M+
Industry News
Ferring Acquires Sciatica Candidate from Seikagaku for Up to $95M
Industry News
Ferrer to Acquire Alexza Pharmaceuticals
Industry News
Teva to Acquire Allergan’s Generics Business for $40.5B
News
Dr. Falk Scores Rights to Medigene’s RhuDex for Hepatological, Gastroenterological Indications
News
Takeda Launches New Subsidiary in Peru
1
2
Page 1 of 2
Scroll Up
Scroll Up
